The Robert C. Strauss Neurocognitive Research Program offers access to the latest clinical trials for Alzheimer’s disease and related disorders. Finding new treatments for Alzheimer’s disease is our primary mission. We have also expanded our focus to include other disorders affecting cognition and behavior, such as frontotemporal degenerations and Lewy Body disease.
Northern Light Mood and Memory maintains a strong commitment to giving Mainer’s access to the latest and most promising research therapies without having to go to the large academic centers in Boston or elsewhere. Participation in research trials not only give our patients and families access to potentially game-changing treatments but offers them hope not only for their own future, but their children’s future as well.
Our research program is the largest research program in brain aging, memory loss, and Alzheimer’s disease in northern New England. Our research program is a close collaboration of Northern Light Acadia Hospital and Northern Light Clinical Research. We have key research partnerships with experts in cognitive aging and dementia at Massachusetts General Hospital, The Jackson Laboratory, and the University of Maine.
Recruitment for Alzheimer’s Disease Research Trials
We generally recruit from the Mood and Memory program, but accept referrals for trials from the community, especially for people with normal cognition who are concerned about developing dementia, and patients diagnosed with mild cognitive impairment or Alzheimer’s disease who are motivated to participate in a clinical trial without having to go to Boston. To be considered, please email us email us at MAINAH@northernlight.org.